Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2020-11-01
2021-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-caloric Sweeteners Levels in Breast Milk and Newborn's Blood and Effect on Microbiota's Composition.
NCT03912038
Medicines in Breast Milk and Estimated Infant Exposure
NCT07346716
The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women
NCT04285684
Metformin to Augment Low Milk Supply (MALMS) Study
NCT02179788
Determination of Sufentanil in Breast Milk of Puerpera
NCT03764202
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
The groups are
1. Normal weight (BMI \< 25),
2. Over weight (BMI \> 27),
3. Diabetic
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention groups
The participants will be given a beverage containing four artificial sweeteners (intervention) at baseline
Artificial sweeteners (acesulfame-potassium, sucralose, saccharine, cyclamate)
The intervention is found in light products ingested by millions of people on a daily basis worldwide
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artificial sweeteners (acesulfame-potassium, sucralose, saccharine, cyclamate)
The intervention is found in light products ingested by millions of people on a daily basis worldwide
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give consent
* Able to produce enough amounts of breastmilk
* Danish/English speakers
* Pre-pregnancy BMI below 25 (20 subjects)
* Pre-pregnancy BMI above 27 (20 subjects)
* Diabetes type 1 or 2 (20 subjects)
Exclusion Criteria
* Unable to give consent
* Unable to produce enough amounts of breastmilk
* Non-Danish/English speakers
* If they have consumed artificial sweeteners 24 hours prior to trial
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AS0063221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.